GlobalData tracks 18 drugs in development for Atypical Teratoid Rhabdoid Tumor by 16 companies/universities/institutes. The top development phase for Atypical Teratoid Rhabdoid Tumor is preclinical, with six drugs in that stage.
Bayer looks to expand Kerendia label to include heart failure – Pharmaceutical Technology
The studies will receive sponsorship from the non-profit academic research organisation, CPC Clinical Research, with funding from Bayer. Image Credit: nitpicker / Shutterstock. Bayer has